Teknova Closes $110 Million Upsized Initial Public Offering

June 25, 2021

Palo Alto – Paul Hastings LLP, a leading global law firm, announced today that the firm represented Alpha Teknova, Inc. (Teknova) in its initial public offering and Nasdaq listing. Teknova raised over $110 million in gross proceeds in the IPO, with 6,900,000 shares of its common stock, sold at a price of $16.00 per share. The closing included 900,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares of common stock in the offering. The shares began trading on the Nasdaq Global Market on Friday, June 25, 2021, under the ticker symbol “TKNO.”

Teknova is a leading provider of critical reagents that enable the discovery, research, development and production of biopharmaceutical products such as drug therapies, novel vaccines and molecular diagnostics. The company intends to use the proceeds to, among other things, increase its manufacturing capacity and capabilities, develop new products and services and pursue acquisition opportunities. Cowen and William Blair acted as joint book-running managers for the IPO.

Corporate partners Jeff Hartlin and Elizabeth Razzano led the Paul Hastings team, which included of counsel Melissa Garcia, and associates Regina Mendoza-Diaz and Laura Friedli.

At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.

Practice Areas

Life Sciences and Healthcare

United States

Emerging Growth Companies


Securities and Capital Markets



Corporate, Litigation, Real Estate, Intellectual Property, Life Sciences, and Employment

Becca Hatton


Katy Foster


Miranda Ward

Submission Requests

Firmwide Inquiries

Elliott Frieder

Get In Touch With Us

Contact Us